menu search

Us biopharma co. is attractive, derisked investment, analyst says

Source: Streetwise Reports (11/11/22) With late-stage drug candidates and major near-term catalysts, un...

November 14, 2022, 2:22 pm

Eli lilly stock starts on front foot after rival alzheimer trial fails

Eli Lilly and Co (NYSE:LLY) stock was moving higher as Roche revealed that an experimental rival treatment for Alzheimer's failed in a Phase III clini...

November 14, 2022, 10:09 am

Eli lilly stock starts fresh week on front foot after rival alzheimer trial fails

Eli Lilly and Co (NYSE:LLY) stock was moving higher as Roche revealed that an experimental rival treatment for Alzheimer's failed in a Phase III clini...

November 14, 2022, 10:03 am

What's going on with biogen stock today? - biogen (nasdaq:biib)

Biogen Inc (NASDAQ: BIIB) shares are trading higher Monday after competitor Roche's Alzheimer's candid...

November 14, 2022, 9:48 am

Roche's alzheimer's drug fails to meet goal in long awaited trial

Roche said its Alzheimer's drug candidate could not clearly be shown to slow dementia progression in tw...

November 14, 2022, 1:13 am

Idorsia: it's time to be greedy (technical analysis)

Idorsia's stock is testing its most important overhead resistance and is trying to break out from its long-term downtrend, a rare situation that could...

November 11, 2022, 9:48 am

Here's my top growth stock to buy now

A premium brand with a history of success makes for a nice investment candidate....

November 11, 2022, 8:30 am

Kodiak sciences' (kod) q3 earnings beat, eye candidate in focus

Kodiak Sciences (KOD) reports a narrower-than-expected loss for the third quarter of 2022. The focus is on the lead ...

November 10, 2022, 3:48 pm

Nike co-founder phil knight on election donations: i do not expect everyone to agree with me

Nike co-founder Phil Knight joins CNBC's 'Squawk Box' to discuss why he donated millions to candidates ...

November 10, 2022, 7:40 am

Pulmonx: an ideal takeout candidate

Pulmonx has an FDA-approved technology to treat severe emphysema. The company estimates its valve treatment is a $12 billion market opportunity....

November 10, 2022, 2:29 am

Shares of truth social merger partner fall after trump's candidates underwhelm in midterm elections

Shares of Truth Social- SPAC drop after Trump's candidates underwhelm in midterm election...

November 9, 2022, 9:07 am

Masonic cancer center, university of minnesota to present data in poster presentation from the phase 1 clinical trial to evaluate hcw9218 in solid tumors at the sitc 37th annual meeting

Presentation includes data on safety and dosage escalationand immune system reaction to HCW9218 No incidence of mucosal bleeding resulting from the HC...

November 8, 2022, 12:00 pm

Immunovant's (imvt) q2 earnings in line, batoclimab in focus

Immunovant's (IMVT) earnings meet estimates in the fiscal second quarter ending Sep 30, 2022. IMVT deepens focus on developing its lead ...

November 7, 2022, 3:03 pm

What is going on with phunware (phun) stock today?

The shares of Phunware (NASDAQ: PHUN ), which develops and manages mobile applications, are surging 17% in early trading today. PHUN stock is soaring ...

November 7, 2022, 10:17 am

Icad: another great candidate for my 'bio boom' speculative portfolio

The ongoing market-wide sell-off has been ruthless against small-cap tickers, but the comprehensive selling has uncovered iCAD. The ticker is currentl...

November 4, 2022, 6:23 pm

Tamarack valley: clearwater or bust

Tamarack Valley Energy Ltd.'s Clearwater expansion enhances the attractiveness of this company as an acquisition ...

September 8, 2022, 4:35 pm

Glaukos (gkos) up on positive glaucoma study data on idose tr

Glaukos' (GKOS) targeted injectable implant candidate, iDose TR, achieves a non-inferior reduction in I...

September 8, 2022, 1:32 pm

Moleculin selected to present at the 2nd annual marie sklodowska-curie symposium on cancer research and care

HOUSTON , Sept. 8, 2022 /PRNewswire/ -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical comp...

September 8, 2022, 8:45 am

Iveric bio (isee) posts positive top-line data from ga study

IVERIC bio (ISEE) reports positive top-line data from the phase III GATHER2 study, evaluating its investigational ...

September 7, 2022, 3:03 pm

Mindset pharma files 16 national patent applications to protect family of novel next-generation psychedelics

Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) said it has filed 16 national patent applications, including in the principal South East Asian markets to p...

September 7, 2022, 9:04 am


Search within

Pages Search Results: